A practical guide for evaluating a HIPAA-compliant medical imaging platform for clinical trials, covering de-identification, audit trails, 21 CFR...
QMENTA launches Central Review to address the longitudinal consistency problem that derails long-duration oncology and CNS trials
Veteran CRO executive and investor brings more than 30 years of clinical research leadership and deep pharma networks to the Barcelona-based medical...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...
Boston, MA, March 29, 2023— QMENTA, Inc. announced today that John E. Kelly III, PhD has been appointed to the company's Board of Advisors. Dr. Kelly...
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has...
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses